购物车
全部删除
您的购物车当前为空
别名 WAIF1, TPBG, M6P1, 5T4AG, 5T4
Anti-5T4/TPBG Antibody (9P872) 是一种抗体,靶向 5T4/TPBG。Anti-5T4/TPBG Antibody (9P872) 可用于 ELISA,FCM。
Anti-5T4/TPBG Antibody (9P872) 是一种抗体,靶向 5T4/TPBG。Anti-5T4/TPBG Antibody (9P872) 可用于 ELISA,FCM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μL | ¥ 1,305 | 5日内发货 | |
| 100 μL | ¥ 2,180 | 5日内发货 |
| 产品描述 | Anti-5T4/TPBG Antibody (9P872) is an antibody targeting 5T4/TPBG. Anti-5T4/TPBG Antibody (9P872) can be used in ELISA,FCM. |
| 别名 | WAIF1, TPBG, M6P1, 5T4AG, 5T4 |
| Ig Type | hIgG1 |
| 克隆号 | 9P872 |
| 交叉反应 | Human |
| 验证活性 | Overlay Peak curve showing MCF7 cells stained with TMAH-01209 (red line) at 1:100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-human IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was human IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed. |
| 应用 | ELISAFCM |
| 推荐剂量 | FCM:1:50-1:200. |
| 抗体种类 | Monoclonal |
| 亚细胞定位 | Cell membrane; Single-pass type I membrane protein. |
| 组织特异性 | Expressed by all types of trophoblasts as early as 9 weeks of development. Specific for trophoblastic cells except for amniotic epithelium. In adult tissues, the expression is limited to a few epithelial cell types but is found on a variety of carcinoma. |
| 构建方式 | Recombinant Antibody |
| 纯化方式 | Affinity-chromatography |
| 性状 | Liquid |
| 缓冲液 | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| 研究背景 | May function as an inhibitor of Wnt/beta-catenin signaling by indirectly interacting with LRP6 and blocking Wnt3a-dependent LRP6 internalization. |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Protein: Human TPBG Protein |
| 抗原种属 | Human |
| 基因名称 | TPBG |
| 基因ID | |
| Uniprot ID | |
| 研究领域 | Stem Cells |
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
评论内容